$ISIS Recent Headlines Health-care-related stocks keep on

New Post Public Reply Private Reply Replies (0) Message Board

Mar 4, 2014 at 11:19 AM

$ISIS Recent Headlines

Health-care-related stocks keep on giving 12:02 p.m. Feb. 12, 2014 - The Trading Deck
See the future 12:42 p.m. Feb. 3, 2014 - Cody Willard
Charting the S&P 500’s excellent 2013 adventure 11:59 a.m. Dec. 23, 2013 - Michael Ashbaugh
Market technicals tame despite debt-ceiling debate 10:43 a.m. Sept. 25, 2013 - Michael Ashbaugh
Isis reaches a new high on tests for treatment of muscular disorder 2:03 p.m. Sept. 19, 2013 - Russ Britt
Isis, Biogen working on ways to fight disease through gene altering 9:59 a.m. Sept. 9, 2013 - Russ Britt
Isis, Novartis, Halozyme all rise on positive product news 10:48 a.m. Sept. 3, 2013 - Russ Britt
Despite positive tests, investors let some air out of Isis Pharmaceuticals 10:30 a.m. July 22, 2013 - Russ Britt
5 stocks to watch 2:35 p.m. July 11, 2013 - The Trading Deck
Onyx share surge lifts several boats in biotech harbor, including ETFs 10:33 a.m. July 1, 2013 - Russ Britt
S&P’s 50-day average marks the technical test 10:39 a.m. June 27, 2013 - Michael Ashbaugh
After the close: Alexion climbs on FDA news, Biogen basks in glory 4:35 p.m. June 26, 2013 - Russ Britt
After dramatic moves, Isis and Allergan dart in different directions 5:18 p.m. June 25, 2013 - Russ Britt
Dissecting the close: Isis soars on data, while Pfizer loses on spin-off 6:26 p.m. June 24, 2013 - Russ Britt
3 ways to play the biotech boom 6:01 a.m. June 3, 2013 - Jeff Reeves
S&P 500 holds the 50-day average — barely 10:41 a.m. April 18, 2013 - Michael Ashbaugh
Biogen inks drug-development deal with Isis 2:06 p.m. Dec. 10, 2012 - MarketWatch.com
Isis: progress in early-stage study of cancer drug 7:53 a.m. Oct. 31, 2012 - MarketWatch.com
Isis Pharma rises 9% in premarket 6:22 a.m. Oct. 19, 2012 - Steve Gelsi
Investing in ‘junk DNA’ 9:28 p.m. Sept. 11, 2012 - Jen Wieczner

Cramer's Mad Money - Much Ado About Baidu (3/3/14) 6:08 a.m. Today - Seeking Alpha
Jim Cramer's Top Stock Picks: BIDU GNC VSI ISIS 6:00 a.m. Today - TheStreet.com
Jim Cramer's 'Mad Money' Recap: Stop Panicking 8:08 p.m. March 3, 2014 - TheStreet.com
US Stock Futures Tumble Ahead Of Economic Data 6:20 a.m. March 3, 2014 - benzinga.com
10-K: ISIS PHARMACEUTICALS INC 6:06 a.m. March 3, 2014 - Edgar Online - (EDG = 10Q, 10K)
Isis' CEO Discusses Q4 2013 Results - Earnings Call Transcript 5:32 p.m. Feb. 28, 2014 - Seeking Alpha
Isis Pharmaceuticals (ISIS) Is Water-Logged And Getting Wetter Today 2:29 p.m. Feb. 28, 2014 - TheStreet.com
3 Stocks Pulling The Health Care Sector Downward 12:02 p.m. Feb. 28, 2014 - TheStreet.com
Silence Therapeutics A Quieter Name In RNAi 6:38 p.m. Feb. 27, 2014 - Seeking Alpha
Biotech Stock Roundup: Isis Soars on Positive Data, Onconova Falls - Analyst Blog 10:26 a.m. Feb. 26, 2014 - Zacks.com
Growth Stocks: 7 Rallying Stocks With No Profits (Yeta????) 5:51 p.m. Feb. 24, 2014 - TheStreet.com
Isis Pharma Soars on Positive Data - Analyst Blog 1:30 p.m. Feb. 24, 2014 - Zacks.com
ISIS reiterated a Buy at Deutsche after data 11:03 a.m. Feb. 21, 2014 - Seeking Alpha
Isis therapy for spinal muscular atrophy provides encouraging results 7:41 a.m. Feb. 21, 2014 - Seeking Alpha
Isis Pharmaceuticals (ISIS): Today's Featured Drugs Laggard 5:01 p.m. Feb. 18, 2014 - TheStreet.com
Positive Opinion on Isis Pharma's ISIS-TTRRx - Analyst Blog 11:50 a.m. Feb. 18, 2014 - Zacks.com
Isis to get another $9M from Biogen 9:15 a.m. Feb. 13, 2014 - Seeking Alpha
Canadian Nod for Aegerion's Juxtapid - Analyst Blog 4:45 p.m. Feb. 11, 2014 - Zacks.com
OncoGenex Has A Potential Blockbuster Drug, But The Markets Are Pricing It Like An Orphan 9:25 a.m. Jan. 28, 2014 - Seeking Alpha
Jim Cramer's Top Stock Picks: ISIS JAZZ SYY ETH IBM 6:00 a.m. Jan. 28, 2014 - TheStreet.com

Isis Reports Financial Results And Highlights For 2013 8:30 a.m. Feb. 28, 2014 - PR Newswire - PRF
Isis Pharmaceuticals to Present at the Cowen 34th Annual Health Care Conference 7:00 a.m. Feb. 25, 2014 - PR Newswire - PRF
Critical Alerts For Cisco Systems, Michael Kors, Whole Foods Market, MetLife, and Isis Pharmaceuticals Released By InvestorsObserver 9:31 a.m. Feb. 24, 2014 - PR Newswire - PRF
Brookdale Senior Living hits 5 year high on Emeritus Acquistion; eBay acquires PhiSix 12:26 a.m. Feb. 24, 2014 - ACCESSWIRE
Isis Pharmaceuticals Reports Interim Results from ISIS-SMN Rx Phase 2 Study in Infants with Spinal Muscular Atrophy 5:00 p.m. Feb. 21, 2014 - PR Newswire - PRF
Isis Pharmaceuticals Reports Interim Results from ISIS-SMN Rx Multiple Dose Study in Children with Spinal Muscular Atrophy 7:00 a.m. Feb. 21, 2014 - PR Newswire - PRF
Webcast Alert: Isis Pharmaceuticals' 2013 Financial Results and Highlights Conference Call 5:01 p.m. Feb. 20, 2014 - PR Newswire - PRF
Isis Pharmaceuticals to Present at the 2014 RBC Capital Markets Global Healthcare Conference 7:00 a.m. Feb. 19, 2014 - PR Newswire - PRF
Isis Announces Positive Opinion on European Orphan Drug Designation for ISIS-TTR Rx 1:32 p.m. Feb. 14, 2014 - PR Newswire - PRF
Isis Pharmaceuticals Advances ISIS-SMN Rx in Infants and Children with Spinal Muscular Atrophy 7:00 a.m. Feb. 13, 2014 - PR Newswire - PRF
Isis Pharmaceuticals to Present at the Leerink Global Healthcare Conference 7:00 a.m. Feb. 6, 2014 - PR Newswire - PRF
Joseph Loscalzo, M.D., Ph.D., Joins Isis Pharmaceuticals' Board of Directors 2:47 p.m. Feb. 3, 2014 - PR Newswire - PRF
RXI Pharmaceuticals Could Benefit from Biotech Industry Dynamics 10:06 a.m. Jan. 24, 2014 - ACCESSWIRE
Isis Pharmaceuticals to Receive $7.5 Million from Alnylam 4:30 p.m. Jan. 13, 2014 - PR Newswire - PRF
Critical Alerts For GM, Isis Pharmaceuticals, Boston Beer, MasterCard, and Macy's Released By InvestorsObserver 9:31 a.m. Jan. 13, 2014 - PR Newswire - PRF
Upcoming Presentations and Stock Price Movements - Research Report on Bard, Regeneron, Alexion, Seattle Genetics, and Isis Pharmaceuticals 8:00 a.m. Jan. 9, 2014 - PR Newswire
NIH Data Sharing Projects Could Accelerate RNAi Field 11:16 a.m. Jan. 8, 2014 - ACCESSWIRE
Isis Pharmaceuticals to Present at the 32nd Annual J.P. Morgan Healthcare Conference 7:00 a.m. Jan. 6, 2014 - PR Newswire
Market Technicals on Thursday: Quest Diagnostics, Santarus, Isis Pharma, and Community Health Systems 8:00 a.m. Dec. 26, 2013 - PR Newswire
Stock Price Movements of Healthcare Companies- Research Report on LabCorp, Isis Pharmaceuticals, Mindray, Clovis Oncology and Sangamo Biosciences 8:00 a.m. Dec. 23, 2013 - PR Newswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Medicare Competitive Bidding May Slash Jobs, Access

Medicare's New Program: Potential Knockout Punch? Today, we dive into Medicare's latest shake-up that might just be the unseen wrecking ball swinging toward thousands of jobs and small businesses in the healthcare sector. Two years from now, starting January 2028, the Competitive Bidding Program is set to reroute the entire landscape for suppliers of key medical products...

ScholarShare 529 Launches $50 Back-to-School Promo

California Families Get a Boost With New 529 Plan Offer Everywhere you turn, it's 'back to school' mania right now, and ScholarShare 529 aims to ride that wave by sweetening the pot for parents ready to think ahead. So here's the gist—California's official college savings plan is handing out a $50 gift card for new accounts opened between now and September 30th. Setting...

Propensity Rockets to No. 70 on the 2026 Inc. 5000 List

Hold onto your hats, folks—Propensity just blasted its way to Number 70 on the Inc. 5000 for 2026. That's quite a leap from the 2,591 spot just last year. If you're scratching your head wondering what's behind this meteoric rise, it’s all about AI and knowing which buyer signals really matter. The AI Advantage in B2B The B2B marketing space isn't exactly the new Wild...

2026 CEE Awards Highlight Energy Innovation Leaders

Showcasing Cutting-Edge Home Energy Innovations It's that time of year again when the brightest innovators in home energy solutions get a nod from the Consortium for Energy Efficiency (CEE). This year's Integrated Home Competition spotlighted five trailblazing products that promise to reshape how we think about energy efficiency, demand flexibility, and sheer user comfort...

OrthoAtlanta Expands with Dr. Smith's Expertise Hire

OrthoAtlanta Welcomes New Orthopedic Surgeon In a world where healthcare organizations are constantly stretching their wings, this new addition of Dr. Carson J. Smith to the fold at Piedmont Orthopedics | OrthoAtlanta stands out. This isn't just some cosmetic face-lift, folks. It's a real investment in the community, not to mention a crucial broadening of what this...

TGI Fridays Unveils New 3 For All Menu Options

Hedging Bets on New Dining Strategies Oh, the restaurant battlefield—where one day you're the toast of the town, and the next, you're hustling to keep those seats filled. TGI Fridays, a name as synonymous with casual eats as long as I’ve been in this game, is rolling the dice with a new offering dubbed '3 For All.' Doesn't sound like your average meal deal either....

NOAA Taps ICEYE US for Game-Changing SAR Satellite Data

The Strategic Move to SAR Data Imagine this: You’re in the thick of a hurricane, where visibility goes out the window, and traditional satellite data chokes under the crushing weight of clouds and nightfall. That's the precise chaos ICEYE US is cutting through with its Synthetic Aperture Radar (SAR) technology. The latest scuttlebutt is that NOAA's getting cozy with...

B2B Growth Hinges on Narrative Coherence, Study Shows

Clear Stories, Stronger Growth If companies can't tell a clear story that their buyers understand and believe, they're destined to stagnate. That's the blunt reality kompeld is pushing with their H2 2026 Narrative Coherence Benchmark. The report scores 150 B2B tech companies on their narrative coherence, showing there's a stark correlation between storytelling and growth....

Citrine Finalizes Sale of Illinois Senior Living Asset

Citrine's Strategic Exit from River Glen Every now and then, you see a company pull off something that makes you nod and say, "That was smart." Citrine Investment Group's sale of River Glen of St. Charles fits that bill. For those keeping tabs, this wasn't some quick flip—Citrine worked on the rock for a good while before cashing in. They secured River Glen back in...

Ransoms and Mega-Losses Surge in Cyber Claims Study

Cyber Costs Skyrocket in Latest Study NetDiligence’s 2026 Cyber Claims Study isn't just another report—it’s a wake-up call. The numbers paint a stark picture: cyber incidents are burning deeper holes in pockets, and no one's immune. Whether you're a scrappy SME or a lumbering corporate giant, this report puts a magnifying glass to the chilling reality of cyber...